ADAGIO MEDICAL HOLDINGS INC
ADGMNASDAQπ #5199 by market capUS Equity
$1.49βΌ $0.11 (β6.88%)
Market closed Β· at closeTrack ADGM
Get earnings, price moves & breaking news on Telegram
24hβΌ 6.9%
7dβΌ 22.8%
14dβΌ 21.7%
30dβΌ 52.7%
ytdβΌ 95.1%
1yβΌ 93.8%
π¦Market Cap
$41M
Small Cap
πRevenue Growth (YoY)
β
πGross Margin
β
π΅FCF Margin
β
βοΈP/S Ratio
β
Otter Score
β
Insufficient data
Trading Snapshot
- Day Range
- $1.49 β $1.49
- 52-Week Range
- $1.45 β $50.70
- Volume (shares)
- 136
- Avg Volume (shares)
- β
- Shares Outstanding
- 27.4M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- β
- Last Q Revenue
- β
- P/E Ratio
- β
- P/S Ratio
- β
- EPS (TTM)
- $-24.10
- Dividend Yield
- β
- Dilution (1yr)
- +35.5%
ADAGIO MEDICAL HOLDINGS INC
ADGMFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0βΌ β100.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-620.1%β² +84.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
β$22MβΌ β65.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$19MβΌ β37.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
671Kβ² +35.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
β$5MβΌ β$9M YoY
About ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings, Inc. is an innovative biotechnology firm dedicated to revolutionizing the treatment of cardiac arrhythmias through advanced medical technologies. Utilizing its proprietary platform, the company is spearheading the development of targeted ablation techniques that address significant unmet needs in the electrophysiology sector. Supported by a robust product pipeline and a seasoned leadership team, Adagio represents an attractive investment opportunity for institutional investors seeking growth in the healthcare space while contributing to improved outcomes in cardiac patient care.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
π§Dilutionβ
β
β
β
β
Overall Score
Insufficient data
β/100
Analyst data unavailable.
Latest News & Updates
News unavailable.